TDT (TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE) NUCLEAR / EDTA BLOOD

image not found

NABL Cap Accredited    
This test detects nuclear Terminal Deoxynucleotidyl Transferase (TdT), an enzyme commonly expressed in immature lymphoid cells. It is primarily used in the diagnosis and classification of acute lymphoblastic leukemia (ALL) and related hematological disorders. The analysis helps clinicians differentiate between various types of leukemias and lymphomas for accurate treatment planning. Metropolis Healthcare performs this test using advanced immunophenotyping techniques for precise diagnostic support

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,440.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: T0038

Frequently Asked Questions (FAQ's):

What does the TdT Nuclear test measure?
It detects the presence of TdT enzyme within immature lymphoid cells.

Why is this test performed?
It helps diagnose and classify acute leukemias, especially ALL.

Do I need to prepare before this test?
No special preparation is required for an EDTA blood sample.

Who should undergo this test?
Patients suspected of leukemia or those requiring further immunophenotypic evaluation.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced staining and analytical techniques to identify TdT-positive cells accurately.

Can this test confirm leukemia on its own?
It supports diagnosis but is interpreted along with clinical findings and other laboratory tests.

Is this test useful for monitoring treatment?
Yes, it may assist in evaluating disease status during or after therapy.

Are Metropolis Healthcare results reliable?
Yes, results follow strict quality-control measures and validated hematology protocols

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab